Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

ADAM17 could be a potential target for treating PCOS.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Testosterone therapy increases bone density in older men with low testosterone levels.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.